Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
MiNK Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$0.7

2024-10-29

Market Capitalization

$28.9 M

2024-10-29

CreditSafe Score

?
Score changed on May 19, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2021FY, 2022FY, 2023FY, 2024
General and administrative expense4.6M7.8M7.4M4.3M
Operating expense total30.9M14.3M
EBIT(28.4M)(30.9M)(22.9M)(11.3M)
Interest expense253.3K463.3K93.0K
Net Income(30.2M)(28.0M)(22.5M)(10.8M)
EPS(0.8)(2.9)

Footer menu